HitGen Ltd. burst onto the drug discovery scene in China merely a year ago, when the Chengdu, Sichuan province-based biotech signed a collaboration agreement with Johnson & Johnson, to use its own platform to build a DNA encoded library and to screen new targets with a focus on oncology and metabolic disorders.
HitGen is to provide chemistry and biological support for screening small molecular lead compounds as part of the deal, following...